MENU

To enhance the quality and validity of research results generated by member-institutions of the Central Luzon Health Research and Development Consortium (CLHRDC), a Training on Data Processing and Analysis was held on November 22-23, 2013 at Holy Angel University, Angeles City, Pampanga.

 

Professors from the Department of Epidemiology and Biostatistics, College of Public Health, University of the Philippines – Manila, Ms. Kim L. Cochon and Ms. Maylin C. Palatino were the trainers. They are noted for being statistical consultants in a number of researches. They gave lectures on data processing and analysis, data entry and editing and the different statistical tools such as Chi-Square, One-way ANOVA, T-test and Simple Linear Regression. Both speakers emphasized the importance of using the correct statistical tool in the interpretation of research data especially in quantitative research.

 

In keeping with its mandate of developing an active and productive health research culture in the region, CLHRDC plans to continue providing other skills enhancement trainings for its members.

Central Luzon is known to have an abundant source of natural resources which could be a good source of potential bioactive constituents with pharmaceutical plant activities. With this, the Central Luzon Health Research and Development Consortium (CLHRDC) – Capacity Building Committee conducted a Training on Isolation and Purification of Bioactive Constituents from Herbal Plants on October 23-24, 2013 at the Angeles University Foundation, Angeles City, Pampanga. It aimed to capacitate health researchers in Region III in the field of drug discovery and development and was attended by participants from member-institutions who are involved in the said field of research.

 

Dr. Irene M. Villaseñor, a Professor from the Institute of Chemistry, UP Diliman was the resource speaker. She is the Chair of Division X also known as the Chemical Sciences Division of the National Research Council of the Philippines and author of numerous scientific publications. She started the session by a lecture regarding the process and concepts of drug discovery and development, isolation and purification which was then followed by a laboratory workshop.

 

This capability building training can hopefully pave the way to tap into research funding offered by the Philippine Council for Health Research and Development (PCHRD) specifically in the Drug Discovery and Development. Under the Regional Research Fund (RRF), the said agency is providing PhP 300,000.00 for a qualified project.  This fund is a tool to encourage new researchers to be actively involved in health research activities without having to compete with more experienced researchers and obtain experience by implementing simple yet relevant health research projects. This funding opportunity also encourages research collaboration among state universities and colleges (SUCs), private higher education institutions and government R&D institutes in the region.

The participants with the Capacity Building Committee and Dr. Villaseñor.

The Central Luzon Health Research and Development Consortium (CLHRDC) is pleased to announce its call for capsule research proposals in the field of health R&D for possible funding in FY 2014 by the Philippine Council for Health Research and Development (PCHRD) of the DOST. This program is open to all interested researchers and faculty members from the CLHRDC member-institutions.

 

PCHRD is offering funding support under the Regional Research Fund mechanism up to a maximum amount of PhP 300,000.00 for a qualified project.  This fund is a tool to encourage new researchers to be actively involved in health research activities without having to compete with more experienced researchers and obtain experience by implementing simple yet relevant health research projects. It also encourages research collaboration among state universities and colleges (SUCs), private higher education institutions and government R&D institutes in the region.

 

In order to be eligible for funding assistance under the RRF, research proposals must be aligned with the 2011-2016 Research Priorities of the PCHRD. Proposals will be selected and endorsed to PCHRD after undergoing evaluation by the CLHRDC Research Management and Ethics Review Committees. The priority research areas include the following:

1. Drug Discovery and Development:

Discovery of new drugs from natural substances (herbal and marine/terrestrial sources) which can be developed up to the pre-clinical stage for common infectious diseases and lifestyle-related disorders.

2. Development of Diagnostic kits for Priority Diseases:

Development of diagnostic tests (point of care and confirmatory) for priority infectious and lifestyle-related diseases for the early detection and/or prediction of disease and mortality, utilizing existing technologies that are off-patent or lapsed technology and/or novel technology.

(dengue and dengue-like illnesses; MDR/XTR TB; drug-resistant malaria; influenza-like illnesses leptospirosis; sepsis; myocardial infarction; colorectal cancer; stroke, diabetes mellitus; and breast cancers )

3. Genomic and Molecular Technology:

Use of information in the human genome in the design of vaccines, therapeutics, and diagnostic devices or products.

(e.g. biomarkers for early detection of diseases and target markers for treatment; personalized medicine; adult stem cells; biologics)

4. ICT for Health:

Development of user-friendly ICT solutions to accelerate the gathering and processing of health-related information for policy making and to deliver quality health care services.

(e.g. Public health surveillance/health intelligence systems; telehealth services and systems; interface for ICT-enabled devices)

5. Hospital Equipment and Biomedical Devices:

Development of affordable, safe and reliable hospital equipment and biomedical devices. (e.g. ventilator/respirator; prosthesis; minimally-invasive surgery and rehabilitation equipment and e=instruments using optics and robotics)

 

Aside from PCHRD, qualified proposals may also be endorsed by the consortium to other funding agencies such as the DOH-III, CHED-III and DOST-III.

 

 

Capsule proposals should be submitted to the Central Luzon Health Research and Development Consortium, Department of Science & Technology Regional Office No. III, DM Government Center, Barangay Maimpis, City of San Fernando, Pampanga on or before January 15, 2014.

The Department of Science and Technology – Philippine Council for Health Research and Development (DOST-PCHRD) in cooperation with the GruppoMedica Inc. (GMI) is pleased to announce the call for nominations for the 2014 DOST-PCHRD-GruppoMedica Award for Outstanding Undergraduate Thesis in Herbal Medicine.

 

The Award is given to provide motivation for students to undertake relevant and innovative research works on herbal medicine that can lead to practical and/or commercial applications.

 

The search is open to all undergraduate students of Colleges of Pharmacy, Chemistry, Nursing and Arts and Sciences who have completed thesis projects on medicinal plants in the current school year. Nominations must be made by the student’s faculty adviser and should be endorsed by the Dean and the region-based Health Research and Development Consortium (RHRDC) to PCHRD. A maximum of three (3) thesis projects are allowed per school/college.

 

The GruppoMedica Inc. will be giving a cash prize of PhP 60,000 for the first prize winner (PhP 42,000 for the student, PhP 12,000 for the mentor and PhP 6,000 for the school), PhP 40,000 for the second prize winner (PhP 28,000 for the student, PhP 8,000 for the mentor and PhP 4,000 for the school), PhP 20,000 for the third prize winner (PhP 14,000 for the student, PhP 4,000 for the mentor and PhP 2,000 for the school).

 

Nominations may be submitted to the CLHRDC-DOST 3 on or before March 31, 2014. Copies of the guidelines and nomination forms are available at the PCHRD and PNHRS websites.

The Department of Science and Technology – Philippine Council for Health Research and Development (DOST-PCHRD) in collaboration with the Department of Health (DOH) is pleased to announce the opening of nominations for the Outstanding Health Research Award (OHRA) for the year 2014.

 

The Award gives recognition to a research program or project that has demonstrated the link between research and practice through the utilization of research findings in the health delivery system.

 

Any health research program or project may be considered for the Award. Nominations will be done by any institution; members of consortium; scientific, technological and professional societies or associations; research institutes; universities and colleges; and individuals. Self-nomination is not allowed.

 

Two awards will be given: one for the biomedical research category and another one for the health services research category. A cash prize of PhP 500,000 and a trophy await the winners for each category.

 

Nominations may be submitted to the CLHRDC-DOST 3 on or before November 29, 2013. Copies of the guidelines and nomination forms are available at the PCHRD and PNHRS websites.